AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    4,877.00p (mid)

  • Current Change (%)

    1.62%

  • Price

    Bid: 4,861.00p

    Offer: 4,862.50p

  • Today

    High: 4,937.64p

    Low: 4,788.00p

  • This year

    High: 5,508.00p

    Low: 4,194.00p

  • Information

    Volume: 938,131

    Market Cap: £61510.63M


AstraZeneca RNS Feed

Title Release date
Total Voting Rights 15:00 - December 1, 2017
Block listing Interim Review 15:00 - December 1, 2017
EMA accepts Tagrisso submission for 1st-line nsclc 07:00 - November 28, 2017
AZ submits Tagrisso in Japan for 1st-line nsclc 07:00 - November 27, 2017
AZ Fasenra receives FDA approval for severe asthma 07:00 - November 15, 2017
BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA 11:35 - November 10, 2017
AZN: Year-To-Date and Q3 2017 Results Announcement 07:00 - November 9, 2017
Total Voting Rights 15:00 - November 1, 2017
ASTRAZENECA AND ASPEN COMPLETE ANAESTHETICS DEAL 07:03 - November 1, 2017
AstraZeneca tralokinumab update in severe asthma 07:00 - November 1, 2017
US FDA approves AstraZeneca's Calquence for MCL 17:05 - October 31, 2017
AZ and MSD rapidly advance Lynparza in Japan 07:05 - October 23, 2017
US FDA approves Bydureon BCise for type-2 diabetes 07:00 - October 23, 2017
FDA Priority Review for Lynparza in breast cancer 07:00 - October 18, 2017
FDA accepts sBLA file for Imfinzi; priority review 07:00 - October 17, 2017

NOTE: This is based on 295 open tips for this company


Total Number of Share tips :

295

View all AstraZeneca Tips


Company overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today